1. Hijazi, Hadia, Reis, Linda M, Pehlivan, Davut, Semina, Elena V, Lupski, James R. 2022. TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions. In American journal of human genetics, 109, 2270-2282. doi:10.1016/j.ajhg.2022.10.007. https://pubmed.ncbi.nlm.nih.gov/36368327/
2. Albuainain, Fatimah, Shi, Yuwei, Lor-Zade, Sarah, Wilke, Martina, Barakat, Tahsin Stefan. 2024. Confirmation and expansion of the phenotype of the TCEAL1-related neurodevelopmental disorder. In European journal of human genetics : EJHG, 32, 350-356. doi:10.1038/s41431-023-01530-6. https://pubmed.ncbi.nlm.nih.gov/38200082/
3. Rushworth, Linda K, Harle, Victoria, Repiscak, Peter, Leung, Hing Y, Patel, Rachana. 2020. In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. In Life science alliance, 3, . doi:10.26508/lsa.202000770. https://pubmed.ncbi.nlm.nih.gov/33033111/
4. Du, Zixuan, Liu, Hanshan, Bai, Lu, Liu, Song-Bai, Tang, Zaixiang. 2022. A Radiosensitivity Prediction Model Developed Based on Weighted Correlation Network Analysis of Hypoxia Genes for Lower-Grade Glioma. In Frontiers in oncology, 12, 757686. doi:10.3389/fonc.2022.757686. https://pubmed.ncbi.nlm.nih.gov/35280808/
5. Makino, H, Tajiri, T, Miyashita, M, Johnston, J, Gabrielson, E. . Differential expression of TCEAL1 in esophageal cancers by custom cDNA microarray analysis. In Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 18, 37-40. doi:. https://pubmed.ncbi.nlm.nih.gov/15773840/
智鼠故事 
